Furthermore, similar to Fn, E. coli drives resistance to immunotherapy via dual mechanisms—by decreasing the number of tumor-infiltrating CD3+CD8+ T cells and by upregulating PD-L1 expression [32, 46] (Figs. 5, 7). This evidence concerns the gene CD274 and neoplasm.